Ad
related to: astrazeneca stock- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Trade
Search results
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 22 hours agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 5 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
The Motley Fool via AOL· 5 days agoBut if you're interested in a blue chip stock with big plans, it's a good option to invest in. Should you invest $1,000 in AstraZeneca Plc right now? Before ...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 5 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via AOL· 5 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Lifted by Hsbc Holdings PLC
ETF DAILY NEWS· 4 days agoHsbc Holdings PLC raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the ...
AstraZeneca stock upgraded by Goldman, 27% upside seen By Investing.com
Investing.com· 4 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN)...
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
Zacks via Yahoo Finance· 7 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
Motley Fool via Yahoo Finance· 4 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
Compugen hits milestone with AstraZeneca cancer trial By Investing.com
Investing.com· 3 days agoThe trial is a crucial step in evaluating the drug as a first-line treatment for a specific type of...